METACAM 0.5 MG/ML ORAL SUSPENSION FOR CATS

দেশ: অস্ট্রেলিয়া

ভাষা: ইংরেজি

সূত্র: APVMA (Australian Pesticides and Veterinary Medicines Authority)

সক্রিয় উপাদান:

MELOXICAM

থেকে পাওয়া:

Boehringer Ingelheim Animal Health Australia Pty. Ltd.

INN (আন্তর্জাতিক নাম):

meloxicam(0.5mg/mL)

ফার্মাসিউটিকাল ফর্ম:

ORAL SOLUTION/SUSPENSION

রচনা:

MELOXICAM UNGROUPED Active 0.5 mg/ml

প্যাকেজ ইউনিট:

15mL; 30mL; 3mL

শ্রেণী:

VM - Veterinary Medicine

থেরাপিউটিক গ্রুপ:

CAT | CAT - QUEEN | CAT - TOM | KITTEN

থেরাপিউটিক এলাকা:

MUSCULOSKELETAL SYSTEM

থেরাপিউটিক ইঙ্গিত:

MUSCOSKELETAL DISCOMFORT | MUSCULOSKELETAL CONDITIONS | ARTHRITIS | ARTHROSIS | BURSITIS | EXTERNAL MYOPATHY | INFLAMATION OF SOFT TISSUES AN | INFLAMMATION | OSTEITIS | OSTEOARTHRITIS | PAIN | TENDON AND LIGAMENT SPRAINS | TENDONITIS | TENOSYNOVITIS | TRAUMATIC JOINT AND CONNECTIVE

পণ্য সারাংশ:

Poison schedule: 4; Withholding period: WHP: N/A; Host/pest details: CAT: [MUSCOSKELETAL DISCOMFORT, MUSCULOSKELETAL CONDITIONS]; GUINEA PIG: [POST SURGICAL PAIN]; For the alleviation of inflammation and pain in both acute and chronic musculoskeletal disorders.DO NOT use in pregnant or lactating animals as no data has been established. Discard unused product 14 days (3mL size) or 6 months (15/30mL sizes) after initial use.

অনুমোদন অবস্থা:

Registered

অনুমোদন তারিখ:

2023-07-01

তথ্য লিফলেট

METACAM 0.5 MG/ML ORAL SUSPENSION FOR CATS
61575/135229
Product Name:
APVMA Approval No:
Label Name:
METACAM 0.5 MG/ML ORAL SUSPENSION FOR CATS AND GUINEA PIGS
Signal Headings:
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
READ SAFETY DIRECTIONS
Constituent
Statements:
0.5 mg/mL MELOXICAM
Claims:
Alleviation of inflammation and pain in both acute and chronic
musculo-skeletal disorders
such as disco-spondylosis, arthropathy and soft tissue injuries in
cats.
Alleviation of mild to moderate post-operative pain associated with
soft tissue surgery, such
as castration, in guinea pigs.
Net Contents:
3 mL
15 mL
30 mL
Directions for Use:
Restraints:
Contraindications:
This product is contraindicated for use in pregnant or lactating
animals.
This product is contraindicated for use in cats less than 6 weeks of
age.
The product is contraindicated for use in guinea pigs less than 4
weeks of age.
This product is contraindicated for use in animals suffering from
cardiac, hepatic or
clinical renal disease. Especially older cats considered for chronic
treatment should be
screened for pre-existing renal, hepatic or gastrointestinal disorders
or hypovolaemia
(using haematology, serum biochemical analysis and urinalysis as
necessary), before
administration of Metacam 0.5 mg/mL Oral Suspension for Cats and
Guinea Pigs. RLP APPROVED
This product is contraindicated for use in animals where there is the
possibility of
gastrointestinal ulceration or bleeding, or where there is evidence of
a haemorrhagic
disorder or individual hypersensitivity to the product.
Precautions:
Other NSAIDs, diuretics, anticoagulants, aminoglycoside antibiotics
and substances with
high protein binding may compete for binding and thus lead to toxic
effects. Metacam must
not be administered in conjunction with other NSAIDs or
glucocorticosteroids. Concurrent
administration of potential nephrotoxic drugs should be avoided.
Pre-treatment with anti-inflammatory drugs may result in additional or
increased adverse
effects and accor

পণ্য বৈশিষ্ট্য

CS: 1.7.2
Page:
1
MATERIAL SAFETY DATA SHEET
4
of
Infosafe No™
LQ1I9
September 2012
ISSUED by BOEHRING
Issue Date :
METACAM® 0.5MG/ML ORAL SUSPENSION FOR CATS
Product Name :
Not classified as hazardous
1. IDENTIFICATION OF THE MATERIAL AND SUPPLIER
METACAM® 0.5mg/mL ORAL SUSPENSION FOR CATS
PRODUCT NAME
Boehringer Ingelheim Pty. Limited
COMPANY NAME
78 Waterloo Rd North Ryde
NSW 2113 Australia
ADDRESS
1800 038 037
EMERGENCY TEL.
Tel: [phone]
Fax: [phone]
TELEPHONE/FAX
NUMBER
[e-mail]
EMAIL
Alleviation of inflammation and pain in both acute and chronic
musculoskeletal
disorders such as disco-spondylosis, arthrothapy and soft tissue
injuries.
RECOMMENDED USE
2. HAZARDS IDENTIFICATION
Not classified as hazardous
NON-HAZARDOUS SUBSTANCE.
NON-DANGEROUS GOODS.
Hazard classification according to the criteria of NOHSC.
Dangerous goods classification according to the Australia Dangerous
Goods
Code.
HAZARD
CLASSIFICATION
3. COMPOSITION/INFORMATION ON INGREDIENTS
Each mL contains 0.5mg meloxicam; one drop contains 0.017 mg
meloxicam.
COMPOSITION,
INFORMATION ON
INGREDIENTS
NAME
CAS
PROPORTION
INGREDIENTS
Ingredients determined
not to be hazardous
Balance
Meloxicam
(4-hydroxy-2-methyl-N-
(5-methyl-2-thiazolyl)-
2H-1,2-benzothiazine-3-
carboxamide-1,1-dioxide
)
71125-38-7
0.5mg/mL
4. FIRST AID MEASURES
No special precautions required. However, if inhaled, remove affected
person
from contaminated area. Keep at rest until recovered. If symptoms
persist seek
medical attention.
INHALATION
Do not induce vomiting. Wash out mouth thoroughly with water. If
symptoms
develop seek medical attention.
INGESTION
Wash affected area thoroughly with soap and water. If symptoms develop
seek
medical attention. Contact a physician immediately and show the packet
insert
or label to the physician.
SKIN
If in eyes, hold eyelids apart and flush the eyes continuously with
running
water. Continue flushing for several minutes until all contaminants
are washed
out completely. If symptoms develop and persi

নিরাপত্তা তথ্য শীট

ABCD
PRESCRIPTION ANIMAL REMEDY
KEEP OUT OF REACH OF CHILDREN
FOR ANIMAL TREATMENT ONLY
METACAM®
0.5 MG/ML ORAL SUSPENSION FOR CATS
ACTIVE CONSTITUENT PER mL:
MELOXICAM 0.5 mg
Alleviation of inflammation and pain in
both acute and chronic musculoskeletal
disorders
3 ML
090321106/2
Batch No:
Expiry Date:
GTIN: (01)09310717400477
FIRST AID
If poisoning occurs, contact a
doctor or Poisons Information
Centre.
_Phone Australia 131126; New _
_Zealand 0800 764 766 (0800 _
_POISON). _
DISPOSAL
Dispose of empty container by
wrapping with paper and putting
in garbage.
STORE
Store below 25° C
(Air Conditioning).
DISTRIBUTED BY
AUSTRALIA
Boehringer Ingelheim Pty Limited
Animal HealthDivision
78 Waterloo Road
North Ryde NSW 2113
APVMA 61575/62936
NEW ZEALAND
Boehringer Ingelheim (NZ)
Limited
Animal Health Division
Level 1, Unit 9
42 Ormiston Road, East Tamaki
Auckland
RVM. A9832
See www.foodsafety.govt.nz for
registration conditions
3 ML
3 ML
DATE:
08.10.2014
MATERIAL NUMBER:
090321106/2
PRODUCT:
Metacam 0,5 mg/ml OS cat 3 ml
COUNTRY:
AU/NZ
DIMENSIONS:
43 x 43 x 108 mm
SCALE:
1 : 1
7.19pt Point
NUMBER OF COLOURS:
3
Black
T
Pantone 258 C
Pantone 110 C
COLOUR
CODES:
BOEHRINGER INGELHEIM VETMEDICA GMBH
2
ABCD
METACAM®
0.5 MG/ML ORAL SUSPENSION FOR CATS
ACTIVE CONSTITUENT PER mL:
MELOXICAM 0.5 mg
Alleviation of inflammation and pain in
both acute and chronic musculoskeletal
disorders
3 ML
3 ML
READ THE ENCLOSED LEAFLET
BEFORE USING THIS PRODUCT.
DIRECTIONS FOR USE
THIS PRODUCT IS CONTRAINDICATED
FOR USE IN PREGNANT OR LACTATING
ANIMALS AS NO DATA HAS BEEN
ESTABLISHED.
Shake well before use.
DOSAGE AND ADMINISTRATION
Discard unused product 14 days
after initial use.
Should be administered orally
either mixed with food or directly
into the mouth around meal
times.
Initial dose (first day of
treatment) 0.1 mg/kg
bodyweight: 6 drops/kg or 2
maintenance volumes, using the
measuring syringe (kg b.w. scale)
Maintenance dose 0.05 mg/kg
bodyweight: 3 drops/kg or 1
maintenance volume, using the
measuring syringe.
METACAM®
0.5 MG/ML